A detailed history of Massmutual Trust CO Fsb transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 4,539 shares of REGN stock, worth $3.65 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,539
Previous 4,680 3.01%
Holding current value
$3.65 Million
Previous $4.92 Million 2.99%
% of portfolio
0.14%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$1024.09 - $1201.76 $144,396 - $169,448
-141 Reduced 3.01%
4,539 $4.77 Million
Q2 2024

Jul 02, 2024

BUY
$883.2 - $1071.19 $543,168 - $658,781
615 Added 15.13%
4,680 $4.92 Million
Q1 2024

Apr 09, 2024

BUY
$902.69 - $993.35 $46,939 - $51,654
52 Added 1.3%
4,065 $3.91 Million
Q3 2023

Oct 03, 2023

SELL
$692.45 - $844.37 $60,243 - $73,460
-87 Reduced 2.12%
4,013 $3.3 Million
Q2 2023

Aug 01, 2023

SELL
$700.03 - $830.35 $79,103 - $93,829
-113 Reduced 2.68%
4,100 $2.95 Million
Q1 2023

Apr 11, 2023

BUY
$680.49 - $826.97 $87,783 - $106,679
129 Added 3.16%
4,213 $3.46 Million
Q4 2022

Jan 06, 2023

BUY
$705.89 - $766.39 $59,294 - $64,376
84 Added 2.1%
4,084 $2.95 Million
Q3 2022

Oct 07, 2022

BUY
$573.97 - $724.32 $58,544 - $73,880
102 Added 2.62%
4,000 $2.76 Million
Q2 2022

Jul 07, 2022

BUY
$548.35 - $738.84 $305,430 - $411,533
557 Added 16.67%
3,898 $2.3 Million
Q1 2022

Apr 08, 2022

BUY
$595.12 - $698.43 $170,799 - $200,449
287 Added 9.4%
3,341 $2.33 Million
Q4 2021

Feb 09, 2022

BUY
$543.48 - $670.97 $1.65 Million - $2.04 Million
3,034 Added 15170.0%
3,054 $1.93 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $7,564 - $8,936
16 Added 400.0%
20 $11,000
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $1,786 - $2,192
4 New
4 $2,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $86.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.